367
Participants
Start Date
May 23, 2018
Primary Completion Date
April 9, 2019
Study Completion Date
December 30, 2020
MolecuLight i:X Imaging Device
The i:X Imaging Device uses built-in light-emitting diodes (LEDs) emitting 405 nm violet excitation light to illuminate the wound during fluorescence imaging in (FL-Mode). The light excites biological components of the wound and surrounding tissues. Non-biological components may also fluoresce although their presence in wounds is less common, provided the wound has been cleaned following standard care protocols. The resulting wound fluorescence wavelengths emitted are typically between 420 - 700 nm in the visible wavelength spectrum. In FL-mode, a customized fluorescence emission filter, which is mechanically placed in front of the built in imaging sensor and allows real-time capture of wound, limits the visualization of fluorescence to wavelengths between 500-545 nm, which typically appears green in color, and 600-665 nm, which typically appears red in color.
Serena Group Research Institute, Pittsburgh
Armstrong County Memorial Hospital, Kittanning
The Foot and Ankle Wellness Center of Western Pennsylvania, Ford City
Saint Vincent Health Center, Erie
Martin Foot and Ankle, York
Foot and Ankle Center, Bryn Mawr
Saint Mary's Center for Wound Healing, Athens
Royal Research Group, Pembroke Pines
Cleveland Foot and Ankle Clinic, Cleveland
The Wound Treatment Center at Opelousas General Health System, Opelousas
The Heal Clinic, Tulsa
Texas Gulf Coast Medical Group, Houston
El Campo Memorial Hospital, El Campo
New Hope Podiatry Group, Los Angeles
Lead Sponsor
SerenaGroup, Inc.
NETWORK
MolecuLight Inc.
INDUSTRY